Tempus Completes Acquisition of Ambry Genetics
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Tempus AI's COO Ryan Fukushima sells shares worth $2.27 million
Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a ...
Why Tempus AI (TEM) Is Jumping Today
Tempus AI (TEM) is soaring 13% today after investment bank TD Cowen reinstated coverage of the shares with a Buy rating. TEM ...
Tempus AI: In Vogue, But Better To Wait For Some Retracement
Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.
Tempus AI shares rise 5% pre-market on continued momentum, Ambry Genetics acquisition
Shares of Tempus AI , Inc. (NASDAQ:TEM) climbed 5% in pre-open trading Tuesday following the completion of its acquisition of ...
Tempus AI (TEM) Acquires Ambry Genetics in $600M Precision Medicine Push
We recently published a list of Top 10 AI Stocks Trending On Wall Street. In this article, we are going to take a look at where Tempus AI, Inc.
Tempus AI's Flywheel Effect: Monetizing Data In Precision Medicine
Tempus AI claims to have a one-stop-shop, with a flywheel platform that becomes better with each new client. See why I rate TEM stock a buy.
360dx1d
TD Cowen Reinstates Buy Rating for Tempus AI, Raises Price Target to $74
The bank had suspended its rating and price target for Tempus during its $600 million acquisition of Ambry Genetics due to TD Securities' involvement in the deal.
Los Angeles Times2y
Honoree: Linh H. Le
Linh H. Le is an accomplished finance and accounting executive with extensive knowledge and expertise that he has implemented at such companies as Ambry Genetics, Medtronic, Disney, Fox ...